A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kristin Baird, MD
National Cancer Institute - Pediatric Oncology Branch
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama
Birmingham, Alabama, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Ucla/mattel'S Children'S Hospital
Los Angeles, California, United States
- Usc/norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
- Stanford University
Palo Alto, California, United States
- Ucsf
San Francisco, California, United States
- Sarcoma Oncology Center
Santa Monica, California, United States
- University of Florida
Gainesville, Florida, United States
- University of Miami
Miami, Florida, United States
- Indiana University
Indianapolis, Indiana, United States
- University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, United States
- National Cancer Institute
Bethesda, Maryland, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- St. Jude Children'S Research Hospital
Memphis, Tennessee, United States
- Seattle Cancer Care Alliance/university of Washington Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2009
- Primary completion
- 31 Aug 2017
- Completion
- 31 Dec 2017
- Last update posted
- 18 Jan 2020
- Registered enrollment
- 38
- Registry id
- NCT00752206
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.